Results 121 to 130 of about 21,592 (229)

Baseline and follow-up data for non–alendronate and alendronate patients.

open access: yes, 2013
Abbreviations: BMD, bone mineral density; BUN, blood urea nitrogen; C-Ca, serum corrected calcium; Cr, blood creatinine; CMV, cytomegalovirus; DM, diabetes mellitus; FN, femoral neck; H, hip; HBV, hepatitis B virus; HCV, hepatitis C virus; LS, lumbar ...
Ping-Chin Lai (297993)   +3 more
core   +1 more source

Efficacy and Safety of Generic Alendronate for Osteoporosis Treatment

open access: yes
Atthakorn Jarusriwanna,1,* Saran Malisorn,1,* Sirikarn Tananoo,1 Kwanchanok Areewong,2 Supachok Rasamimongkol,1 Artit Laoruengthana1 1Department of Orthopaedics, Faculty of Medicine, Naresuan University, Phitsanulok, Thailand; 2Department of ...
Areewong K   +5 more
core  

In-vitro release of alendronate sodium from different formulations.

open access: yes, 2018
In-vitro release of alendronate sodium from different formulations.
Waleed Yousof Rizg (5328671)   +1 more
core   +1 more source

Alendronate treatment rescues the effects of compressive loading of TMJ in osteogenesis imperfecta mice

open access: yesProgress in Orthodontics
Background Osteogenesis imperfecta (OI) is a genetic disorder of connective tissue caused by mutations associated with type I collagen, which results in defective extracellular matrix in temporomandibular joint (TMJ) cartilage and subchondral bone.
Po-Jung Chen   +3 more
doaj   +1 more source

Effects of Alendronate, Calcitonin and Raloxifene Used in the Treatment of Postmenopausal Osteoporosis On Serum No Levels

open access: yes, 2005
The aim of the present study was to evaluate the effects of alendronate, calcitonin and raloxifene used in the treatment of postmenopausal osteoporosis on serum nitric oxide (NO) levels.
Kazım Şenel   +5 more
core  

Radiodensitometric and DXA analyses for the measurement of bone mineral density after systemic alendronate therapy

open access: yesBrazilian Oral Research, 2013
Precise techniques for the measurement of maxillary bone mineral density (BMD) are useful for the early diagnosis of systemic diseases. The aim of this study was to compare in vivo the efficacy of dual-energy x-ray absorptiometry (DXA) and radiographic ...
Marília Pacífico Lucisano   +6 more
doaj  

Five-year alendronate treatment outcome in older postmenopausal Japanese women with osteoporosis or osteopenia and clinical risk factors for fractures

open access: yes, 2009
Jun Iwamoto1, Atsushi Miyata2, Yoshihiro Sato3, Tsuyoshi Takeda1, Hideo Matsumoto11Institute for Integrated Sports Medicine, Keio University School of Medicine, Tokyo, Japan; 2Department of Internal Medicine, Yahata Clinic, Tokyo, Japan; 3Department of ...
Atsushi Miyata   +3 more
core  

The Effect of Alendronate Treatment on Bone Density and Bone Markers in Postmenopausal Osteoporosis

open access: yes, 2002
The objective of this blind, randomized controlled study was to evaluate effect of 12 months alendronate treatment on bone mineral density (BMD) and bone formation, resorption markers in postmenopausal osteoporotic women. Women with BMD values at least 2
S. Akı, N. Eskiyurt, R. G. Gulbaba
core  

Effects of Alendronate and Alfacalcidol on Preventing Bone Loss in Chemotherapy-treated Soft-tissue Sarcoma. [PDF]

open access: yesIn Vivo
Nakanishi M   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy